The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 06, 2006

Filed:

Dec. 14, 2004
Applicant:

Bernhard Keppler, Hockenheim, DE;

Inventor:

Bernhard Keppler, Hockenheim, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 15/00 (2006.01); A61K 31/28 (2006.01);
U.S. Cl.
CPC ...
Abstract

A tumor-inhibiting platinum (II) oxalate complex and its use as a therapeutic agent are provided, in particular as a tumor-inhibiting medicament. The complex may be compounds of the general formula (I), wherein the substituents R, R, R, R, R, R, R, and Rare independently selected from the group consisting of hydrogen, unsubstituted or substituted alkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl and unsubstituted or substituted alkylaryl radicals, the substituents R, R, R, and Rare independently selected from the group consisting of hydrogen, unsubstituted or substituted alkyl, and unsubstituted or substituted alkenyl radicals, and wherein optionally in each case at least two of the substituents R, R, R, R, R, R, R, and Rcan form with one another at least one unsubstituted or substituted alkylene, unsubstituted or substituted alkenylene radical or an unsubstituted or substituted aromatic ring, and wherein optionally at least one of the carbon atoms of the cyclohexane ring bearing the substituents R, R, R, R, R, R, R, and Ris replaced by a heteroatom, and if the heteroatom is oxygen, the substituents R, R, R, R, R, R, R, and Rcan additionally be hydroxy radicals, and pharmaceutically compatible salts of them, provided that at least one of the substituents R, R, R, R, R, R, R, or Ris not equal to hydrogen and the substituents Ror Rand Ror Rdo not form any unsubstituted C-alkylene radical with one another.


Find Patent Forward Citations

Loading…